Pharmaceutical Manufacturing News and Research

RSS

Texas Plant-Expressed Vaccine Consortium announces biotherapeutic manufacturing initiative for infectious diseases

Leaders of the Texas Plant-Expressed Vaccine Consortium today announced a biotherapeutic manufacturing initiative designed to show proof of concept for a landmark new technology that could dramatically increase the nation's capability to produce vaccines for infectious diseases, including influenza.

25 Feb 2010

Texas-based consortium announces biotherapeutic manufacturing initiative for vaccine production

25 Feb 2010

Rondaxe and TD2 announce cancer drug development alliance

TGen Drug Development (TD2) and Rondaxe Enterprises today announced a strategic alliance that will help emerging companies speed new high-quality treatments to cancer patients.

18 Feb 2010

Codexis announces two separate collaborations in pharmaceutical manufacturing

Codexis, Inc. today announced two separate collaborations in pharmaceutical manufacturing with Dishman Pharmaceuticals and Chemicals and AMPAC Fine Chemicals LLC, a subsidiary of American Pacific Corporation. These agreements expand the application of Codexis technology to a broadened pipeline of branded innovator pharmaceutical products.

17 Feb 2010

China Pharma Holdings announces completion of clinical trials for Candesartan

China Pharma Holdings, Inc., which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that the Company has completed clinical trials for Candesartan, an anti-hypertension drug, and submitted the generic drug production application to the SFDA.

21 Jan 2010

Illicit drug consumption in Europe

Europeans belong to the largest consumers of illicit drugs, absorbing about one fifth of the global heroin, cocaine and cannabis supply, as well as one third of ecstasy production (UNODC World Drug report, 2008). However, the vast majority of Europeans have never tried any illicit substance. In popular perception, illicit drugs still represent alien cultures challenging traditional European patterns, including consumption of our favourite drugs - alcoholic beverages.

21 Jan 2010

CEL-SCI completes validation of its GMP manufacturing facility

CEL-SCI Corporation, a late-stage oncology company and a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases, announced today it has completed the validation of all critical utilities and manufacturing equipment at its GMP manufacturing facility in Maryland.

12 Jan 2010

Medical Care Technologies reaches definitive agreement to acquire GUC's technologies

Medical Care Technologies Inc. today announced that it has reached a definitive agreement to acquire various technologies from Great Union Corporation, ("GUC") a private Hong Kong corporation.

12 Jan 2010

NPS awarded two multi-year contracts to provide Alternative Sampling and Marketing programs

Following a highly competitive evaluation process, National Patient Services (NPS) - A Triplefin Company has been awarded two multi-year contracts to provide Alternative Sampling and Marketing programs for two Fortune 50 Pharmaceutical Manufacturing companies.

2 Dec 2009

NIPTE to develop educational programs on leading edge pharmaceutical technology for FDA reviewers

The U.S. Food and Drug Administration (FDA) has awarded the National Institute for Pharmaceutical Technology and Education, Inc. (NIPTE) a $652,000 two-year contract to develop and deliver a professional development program to help to ensure that FDA reviewers are current in state-of-the-art pharmaceutical manufacturing and technology.

25 Nov 2009

DSM Pharmaceutical Products announces manufacturing alliance with Galenix

DSM Pharmaceutical Products today announced that it has made a manufacturing alliance with Galenix, Saint Jean D'Illac, France, where DSM will be the preferred commercial scale manufacturing partner for Galenix commercial products on a global basis.

6 Nov 2009

FluGen's CHO-cell-based production system generates egg-free, 2009 H1N1 influenza vaccine virus

FluGen Inc., an emerging leader in the development, production and delivery of influenza vaccines, today announced that its proprietary CHO-cell-based production system has generated novel 2009 H1N1 influenza vaccine virus without the use of eggs during any step of production.

30 Oct 2009

Schering-Plough announces 2009 third quarter financial results

Schering-Plough Corporation (NYSE: SGP) today reported financial results for the 2009 third quarter.

22 Oct 2009

Drug expert to discuss recent policy shift in medical marijuana at 2009 Symposium

The National Association of Boards of Pharmacy(R) (NABP(R)) welcomes Office of National Drug Control Policy drug policy expert Kevin Sebat to speak at its 2009 Symposium. On December 3, 2009, Sebat will discuss the current federal laws regarding marijuana as well as the recent policy shift regarding prosecution of medical marijuana cases in states that have legalized the practice.

22 Oct 2009

Cambrex wins the CPhI Innovation Award for its Continuous-Flow Microwave-Assisted Organic Synthesis technology

Cambrex Corporation announced today that it won the Silver Innovation Award at the 2009 CPhI Event for its Continuous-Flow Microwave-Assisted Organic Synthesis (CFMAOS) technology. The award was accepted by Dr. Jayne E. Muir (Market Research & New Technologies - Europe), who presented the technology to a panel of judges at this important pharmaceutical ingredients exhibition in Madrid, Spain on October 13, 2009.

21 Oct 2009

Shire Canada supports initiative for further access to antiretroviral medicine for Rwanda

Shire Canada Inc., a division of Shire plc, announced today its voluntary cooperation to enable further royalty-free access to HIV/AIDS medicines for Rwanda as part of ongoing collaborative efforts to improve health and save lives in the developing world.

20 Oct 2009

Stemedica completes pre-IND meeting with the FDA concerning allogeneic mesenchymal bone marrow cells

Stemedica Cell Technologies, Inc., a world leader in stem cell research and manufacturing, announced that it completed its pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding a proposed IND (Investigative New Drug) to evaluate the safety and efficacy of Stemedica's high potency proprietary allogeneic mesenchymal bone marrow-derived stem cells (adult human) as a treatment for ischemic stroke.

20 Oct 2009

Ahura Scientific expands global customer base in China and Germany

Ahura Scientific, Inc., the leader in field-deployed analytical instruments for human health and public safety, today announced an upgrade to the language capabilities of TruScan, its handheld Raman spectrometer designed for the stringent requirements of the pharmaceutical and consumer health industries.

14 Oct 2009

African leaders, Chirac unite to fight fake drug manufacturing, distribution

Leaders from Benin, Burkina Faso, the Central African Republic, Congo-Republic, Niger and Senegal on Monday joined former French President Jacques Chirac in Cotonou, Benin, in a campaign against the manufacturing and sale of fake pharmaceutical products, Reuters reports (Lewis, 10/12).

14 Oct 2009

Hospira and Celltrion agree to develop and market eight biogeneric products

Hospira, Inc., the world leader in generic injectable pharmaceuticals, today signed a Business Cooperation Agreement with South Korea-based Celltrion, Inc. and Celltrion Healthcare, Inc. ("Celltrion"), which outlines the business terms of a future distribution agreement for the United States, Europe, Australia, New Zealand and Canada for eight biogeneric products that are currently under development by Celltrion, five of which are incremental to Hospira's pipeline.

9 Oct 2009